Gang H, Shaw J, Dhingra R, Davie JR, Kirshenbaum LA. Epigenetic regulation of canonical TNF␣ pathway by HDAC1 determines survival of cardiac myocytes. Am J Physiol Heart Circ Physiol 304: H1662-H1669, 2013. First published April 12, 2013; doi:10.1152/ajpheart.00093.2013.-Gene transcription is regulated by post-translation modifications. Histone deacetylases (HDACs) remove acetyl groups from histone and non-histone factors inhibiting transcription. Proinflammatory cytokines such as TNF␣ activate the canonical nuclear factor-B (NF-B) pathway. Earlier we established a cytoprotective role for NF-B in the heart. Though a causal relationship for HDAC1 and NF-B has been established, the impact of HDAC1 on TNF␣ signaling is unknown. Herein, we demonstrate that HDAC1 provides a molecular switch for determining cell survival in the TNF␣ pathway. In contrast to vehicle-treated control cells, TNF␣-treated cells displayed a marked increase in NF-B gene transcription. Notably, cells treated with TNF␣ were indistinguishable from vehicle controls cells with respect to viability. Interestingly, HDAC activity was reduced in cells treated with TNF␣. Conversely, in the presence of HDAC1, NF-B gene transcription by TNF␣ was repressed, resulting in mitochondrial perturbations and widespread cell death. Heterologous fusion proteins comprised of yeast Gal4 DNA binding domain fused in frame to the NF-B p65 transactivation domain were preferentially repressed by HDAC1. Moreover, transcription mediated by Gal4VP16 protein from herpes virus was unaffected by HDAC1 in cardiac myocytes. Mutations that abrogate known catalytic activities of HDAC1, small interference RNA, or pharmacological inhibition of HDAC1 restored NF-B signaling and suppressed cell death induced by TNF␣. These data provide the first evidence for an obligate link between HDAC1 and canonical TNF␣ pathway for cell survival of cardiac myocytes. cardiac myocytes; gene transcription; NF-B; HDAC1; cell death THOUGH THE UNDERLYING MECHANISMS that govern gene transcription and cell survival of cardiac myocytes remain cryptic, there is growing evidence that NF-B may be centrally involved. In cells, NF-B exists as a heterodimeric complex comprised of RelA p65/p50 protein subunits bound to the inhibitor of B (IB) in the cytoplasm (3, 4, 19, 29) . Cytokines such as TNF␣ activate NF-B via canonical IKK signaling complex that triggers the phosphorylation-dependent degradation of IB␣. Ostensibly, degradation of IB␣ unmasks the nuclear localization motif on the p65 subunit, permitting the nuclear translocation of NF-B (12). In the nucleus, the binding of p65 NF-B subunit to its cognate DNA elements affects transcription through its NH 2 -terminal transactivation domain (TAD) (17). Loss of function mutations of the p65NF-B NH 2 -terminal transactivation domain are incompatible with life, highlighting the importance of NF-B gene transcription for cell survival (1, 5, 30, 31) . Indeed, a number of survival genes including SOD, inhibitor of apoptosis proteins 1 and 2, and TNF receptor-associated factors are known transcriptional targets of NF-B (31). A survival role for NF-B is further substantiated by studies in which loss of function of NF-B rendered cells sensitive to TNF␣-induced death (5, 13). Indeed, in the absence of NF-B signaling, cardiac myocytes exhibited mitochondrial perturbations and greater incidence of cell death during hypoxia compared with wild-type controls (2). In fact, interventions that restored NF-B activity were also sufficient to suppress death. Though the majority of studies have focused on the transactivation properties of NF-B, NF-B can in some cases repress gene transcription. Hence, the dichotomous actions of NF-B on gene transcription may be determined by post-translational events that alter its activity in a cell and context-specific manner.
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Epigenetic modifications to histone and non-histone proteins by histone acetyl transferases and histone deacetylases (HDACs) regulate gene transcription, each opposing the actions of the other [reviewed in Sengupta and Seto (25) and Seto (26) ]. For example, in contrast to histone acetyl transferases, which increase gene transcription, HDACs conversely inhibit transcription (9, 11) . Although a role for the class II HDACs (4, 5, 9) for the regulation of cardiac hypertrophy have been extensively demonstrated (9, 18) , a paucity of available information exists for the class I HDACs (1, 2, 3, 8) for cell survival in the heart. Notably, in contrast to the class II HDACs, which are cytoplasmic in absence of activating signal, class I HDACs are constitutively found in the nucleus. This unique difference raises the interesting possibility that class I HDACs may be important for regulating the expression of certain genes under basal conditions. Our previous work demonstrating the ability of p65 NF-B subunit to selectively interact with HDAC1 (27) coupled with a survival role for NF-B in cardiac myocytes prompted us to test whether HDAC1 influences canonical TNF␣ signaling and, if so, the impact on cardiac cell survival. In this report, we provide new compelling evidence that NF-B gene transcription and cell survival are obligatorily linked and mutually dependent on HDAC1.
MATERIALS AND METHODS
Cell culture and transfection. Neonatal ventricular myocytes were isolated from 1-to 2-day-old Sprague-Dawley rats and submitted to primary culture as we previously described (2) . Cells were transfected with eukaryotic expression plasmids or short hairpin interference RNA (shRNA)-directed against HDAC1 24 h after plating under serum-free conditions for up to 36 h using Effectene reagent (Qiagen) as we previously reported (2) . Cardiac myocytes were treated with TNF␣ (10 ng/ml) and HDAC inhibitor trichostatin A (TSA, 10 M) for 24 h in serum-free DMEM/F12 as we previously reported (27) . shRNA directed against HDAC1 was generated using targeting sequence 5=GCA AGC AGA UGC AGA GAU UTT3= (Invitrogen). All animals protocols for isolating cardiac myocytes were reviewed and approved by the Institutional Review Board according to the Institutional Animal Care and Use Committee guidelines.
Luciferase assay. Ventricular myocytes were transfected with a NF-B promoter luciferase reporter plasmid containing tandem binding elements for NF-B (NF-B luc) or the herpes simplex virus thymidine kinase promoter (TK Luc) promoter reporter that lacks NF-B DNA binding elements (14, 27) . Eukaryotic expression plasmids encoding wild-type p65 NF-B or heterologous Gal4 fusion constructs comprised of the Gal4 DNA binding domain fused in frame to the p65 transactivation domain (1, 16) . Expression plasmids encoding wild-type and mutant HDAC1 cDNAs were kindly provided by Dr. James Davie (Cancer Care Manitoba, University of Manitoba) (27) . Cells were lysed 24 h after transfection. Luciferase activity was normalized to ␤-galactosidase activity to control for transfection efficiency. Data are presented as means Ϯ SE as fold change from vector (pcDNA3) controls.
Cell viability assay. Cell viability was determined by epifluorescence microscopy using vital dyes calcein-AM and ethidium homodimer-1 to visualize the number of living (green) and dead (red) cells, respectively. Cell viability was determined by counting Ն200 cells from n ϭ 3 replicates from n ϭ 3 to 4 independent myocyte isolations for each condition tested. Data are expressed as means Ϯ SE percent dead cells from control.
Mitochondrial membrane potential. Mitochondrial membrane potential (⌬⌿ m) in cells was assessed by epifluorescence microscopy. Cells were preincubated with 50 nM tetramethylrhodamine methyl ester perchlorate (TMRM, Molecular Probes, Eugene, Oregon) (24) .
Histone activity assay. HDAC activity was monitored in cardiac myocytes using a fluorogenic assay as per the manufacturer's instructions (UpState Cat No. .
Statistical analysis. Multiple comparisons between groups were determined by one-way ANOVA. Unpaired two-tailed Student's t-test was used to compare mean difference from control. Differences were considered to be statistically significant to a level of P Ͻ 0.05. In all cases the data were obtained from at least n ϭ 3 to 4 independent myocyte isolations using n ϭ 3 replicates for each condition tested.
RESULTS
To establish whether HDAC1 influences NF-B-dependent gene transcription and cell survival, we assessed the impact of HDAC1 on NF-B reporter (NF-Bluc) gene transcription by the p65 NF-B subunit. For these studies, we focused our attention on the p65 NF-B, since earlier work by our laboratory established p65 subunit was necessary and sufficient for NF-B gene transcription and cell survival in cardiac myocytes. As shown in Fig. 1A , a 4.5-fold increase (P Ͻ 0.01) in NF-B luciferase activity was observed in cells expressing the p65 subunit of NF-B. In contrast, the p65 NF-B subunit had no effect on transcription driven by the herpes virus thymidine kinase promoter (TKluc), which lacks NF-B responsive elements, demonstrating the gene transcription mediated by the p65 NF-B subunit was contingent on the presence of canonical NF-B promoter elements. Since our preliminary findings suggested that HDAC1 may influence NF-B transcription in non-muscle cells, we tested the impact of HDAC1 on NF-B gene-dependent transcription in cardiac myocytes. As shown in Fig. 1B , in contrast to vector control cells, a marked reduction in basal NF-B reporter activity was observed in the presence of HDAC1. Interestingly, the TK luc promoter that lacks NF-B elements was unaffected by p65 NF-B, HDAC1 alone, or in combination (Fig. 1, A-C) . To test whether the observed repression of NF-B reporter activity by HDAC1 was related to inhibition of the p65 NF-B subunit, we tested the effects of HDAC1 on inducible transcription mediated by the p65 NF-B subunit. As shown in Fig. 1D , in contrast to vector control cells, a marked reduction in NF-B reporter activity was observed in the presence of HDAC1. Notably, the inhibitory effects of HDAC1 on NF-B reporter activity were alleviated by the HDAC inhibitor TSA (10 M). Taken together, these findings suggest NF-B gene transcription is impaired by HDAC1 in cardiac myocytes.
Based on these findings, we tested whether the inhibitory effects of HDAC1 on NF-B gene transcription were related to alterations in the DNA binding capacity or transactivation potential of the p65 NF-B subunit. For these studies, we assessed the impact of HDAC1 on heterologous fusion constructs comprised of the yeast GAL4 DNA binding domain fused in frame to the transactivation domain of p65 NF-B subunit (Fig. 1E ). As shown in Fig. 1F , in the absence of a transcriptional activation domain, no basal reporter transcription was observed by Gal4 DNA binding domain alone. In contrast, however, a significant increase in Gal4 gene reporter transcription was observed in cardiac myocytes expressing the heterologous Gal4p65 protein. Moreover, Gal4p65 gene transcription was impaired in cells expressing the wild-type HDAC1 but not in cells expressing the catalytically inactive mutant HDAC1 H141A . Interestingly, the inhibitory actions imposed by HDAC1 on Gal4 reporter transcription were restricted to the p65 transactivation domain, since an alternative Gal4 fusion protein comprised of the herpes virus VP16 transactivation domain Gal4VP16 was unaffected by HDAC1 (Fig.  1G ). These finding suggest that deacetylase activity of HDAC1 inhibits NF-B transcription by impairing the transactivation function of p65 NF-B subunit independent of DNA binding.
Since we established NF-B was important for basal cell survival of cardiac myocytes, we next tested whether cell viability is influenced by HDAC1. As shown in Fig. 2, A and B, in contrast to vector control cells, a marked reduction in mitochondrial ⌬⌿m was observed in cardiac myocytes expressing HDAC1. Concordant with the loss of mitochondrial ⌬⌿m was a corresponding decrease in viability in cells expressing HDAC1 (Fig. 2, C and D) . Importantly, mitochondrial defects and cell death induced by HDAC1 were abrogated by shRNA-directed against HDAC1. These findings suggest that inhibition of basal NF-B-dependent transcription by HDAC1 promotes death.
Previously, we showed that activation of NF-B by TNF␣ to be crucial for cell survival of cardiac myocytes. Therefore, we assessed the physiological impact of HDAC1 on the TNF␣ signaling pathway. As shown in Fig. 3 , A and B, in contrast to the levels of vehicle-treated control cells, a marked increase in p65 NF-B mRNA levels and NF-B-dependent gene transcription was observed in cells treated with TNF␣. Importantly, TNF␣ had no effect on the activity of TK luc promoter, which lacks the "cis-acting" elements for NF-B (Fig. 3C) , a finding concordant with our TK luc activity of p65 and HDAC1, shown in Fig. 1 .
Notably, TNF␣-treated cells were indistinguishable from vehicle-treated controls with respect to mitochondrial ⌬⌿m and cell viability, indicating that TNF␣ was not toxic to myocytes and did not provoke death. As shown in Fig. 3 , D-G, in contrast to cells treated with TNF␣ or vehicle alone, cells treated with TNF␣ in the presence of HDAC1 displayed mitochondrial defects including loss of ⌬⌿m and widespread cell death. Importantly, shRNA directed against HDAC1 completely abrogated the cytotoxic effects of TNF␣. These findings reveal that disruption of the canonical TNF␣-NF-B pathway by HDAC1 promotes cell death of cardiac myocytes.
Furthermore, in complementary experiments to prove that TNF␣ mediated NF-B activation is crucial for cell survival, we assessed the impact of TNF␣ on cell survival in cardiac myocytes rendered defective for NF-B activation. For these studies, cardiac myocytes were infected with an adenovirus Average Fold Activation C § § § encoding a kinase inactive mutant of IKK␤ (IKK␤ K-M ), previously shown by our laboratory to render cardiac myocytes defective for IKK␤ activity, as a means to disrupt the TNF␣ signaling pathway and NF-B activation in cardiac myocytes (23, 27) . As shown in Fig. 4 , A-D, in contrast to vector-treated control cells, a marked increase in mitochondrial perturbations and cell death were observed in cells defective for NF-B signaling treated with TNF␣. These findings substantiate the importance of the canonical TNF␣-NF-B signaling pathway for cell survival of cardiac myocytes. Based on these findings, we reasoned that TNF␣ must activate NF-B by a mechanism that circumvents the otherwise inhibitory actions of HDAC1 on NF-B activity. One possibility includes that TNF␣ promotes the nuclear export of HDAC1, which would relieve the inhibitory actions on NF-B activity, similar to that seen for inactivation of class II HDACs. To address this possibility, we assessed whether TNF␣ influences the nuclear localization of HDAC1. As shown in Fig. 4E , by immunofluorescence microscopy, HDAC1 was expressed in the nucleus of cells in the absence or presence of TNF␣ and indistinguishable from vehicle-treated control cells, indicating that TNF␣ does not influence nuclear export of HDAC1. Another possibility suggests TNF␣ may influence HDAC activity. Interestingly, in contrast to that of vehicle-treated control cells, HDAC activity was markedly decreased in cells treated with TNF␣ (Fig. 4F) . These findings suggest that TNF␣ inhibits HDAC activity independent of its nuclear localization.
DISCUSSION
The findings of the present study are compelling and mechanistically link the deacetylase activity of HDAC1 to cell survival of cardiac myocytes, which to our knowledge has not been reported. Earlier we established NF-B was crucial for regulating gene expression and cell survival of cardiac myocytes (2, 20) . We further demonstrated that loss of NF-B activity triggers mitochondrial perturbations and cell death (2) . Hence the regulation of NF-B activity represents a key nodal point in the regulation of cell survival. In this regard, the cytoplasmic retention of NF-B by IB␣ negatively regulates NF-B activity by preventing its nuclear targeting. Indeed, in absence of an activating signal that would otherwise trigger the phosphorylation-dependent degradation of IB␣, NF-B remains inactive in the cytoplasm (6, 7). However, there is growing evidence including data by our laboratory that NF-B can readily shuttle between cytoplasm and nucleus, resulting in nuclear NF-B in unstimulated cells (1, 8) . The significance of this finding is unknown but suggests that NF-B may regulate the basal activity of genes involved in cell survival. The fact that HDAC1 is constitutively active in the nucleus of cardiac myocytes, coupled with our previous work demonstrating the specificity for HDAC1 to interact with the p65 subunit of NF-B, raised the interesting and tenable possibility that HDAC1 may modulate nuclear NF-B activity and gene expression (27) . Indeed, this view is supported by the fact that NF-B-dependent gene transcription in cardiac myocytes was repressed by HDAC1.
NF-B acetylation is important for gene transcription, inhibition of NF-B activity by HDAC1 coincided with increased cell death. The fact the deacetylase defective mutant of HDAC1 or TSA abrogated cell death underscores the importance of HDAC1 in regulating NF-B activity for cell survival. This notion is substantiated by the fact that inhibition of the acetyltransferase activity of p300 by viral oncoprotein induced cardiac death (14) . Our experiments with the p65Gal4 gal fusion proteins are intriguing and strongly suggest that HDAC1 impairs the transactivation domain of the p65NF-B subunit. Furthermore, the inhibitory actions were restricted to the p65 NF-B, given that transcription driven by the heterologous herpes virus VP16 protein or the thymidine kinase promoter that lacks consensus elements for NF-B were each unaffected by HDAC1. Together, these findings strongly suggest a model in which the regulation of NF-B and survival are operationally linked to HDAC1.
NF-B activation is a crucial component of the TNF␣ pathway for cell survival of cardiac myocytes (20) . Indeed, cardiac myocytes defective for NF-B signaling were sensitized to the cytotoxic effects of TNF␣. Hence, another important feature of our study was the loss of NF-B activity and increased death in cells treated with TNF␣ in the presence of HDAC1. These findings substantiate that the transcriptional activation properties of NF-B are crucial for survival in the canonical TNF␣ pathway. Indeed, we show by not one but by two independent approaches that disruption of NF-B signaling promotes cell death. This observation is concordant with larger infarct sizes in TNF␣ receptor-I knockout hearts, defective for NF-B activation (15) . In that study, however, HDAC activity was not determined. Another interesting aspect of our present work is that nuclear localization of HDAC1 was unaffected by TNF␣, yet HDAC activity was markedly reduced. Based on these findings, we propose a model in which TNF␣ activates NF-B by a mechanism that simultaneously inhibits HDAC1 activity. At present, the underlying mechanism by which TNF␣ inhibits HDAC1 is unknown. However, given that HDAC1 activity is increased by phosphorylation, we speculate that TNF␣ likely alters the phosphorylation status Fig. 1 . Regulation of NF-B gene transcription by Histone deacetylase 1 (HDAC1) in cardiac myocytes. A: postnatal cardiac myocytes were transfected with luciferase promoter reporter constructs for NF-B (NF-Bluc) and herpes simplex virus thymidine kinase (TKluc) which lacks -B consensus elements in the absence and presence of an expression vector encoding p65 NF-B subunit. B: ventricular myocytes were transfected with NF-Bluc and TKluc reporters as detailed in A in the absence and presence of HDAC1. C: postnatal cardiac myocytes were transfected with TKluc in the absence and presence of p65-NF-B and HDAC1. D: effects of wild-type HDAC1 in absence and presence of the HDAC inhibitor trichostatin A (TSA; 10 M) were assessed on NF-B reporter activity. Data are expressed as means Ϯ SE from at least n ϭ 3 to 4 independent myocyte isolations using replicates of n ϭ 3 for each experimental condition tested. *Statistically different P Ͻ 0.05 from vector control (CNTL); §not statistically different from TK luc CNTL; ‡statistically different P Ͻ 0.05 from p65; †statistically different P Ͻ 0.05 from p65ϩHDAC1. E: schematic diagram of the heterologous yeast Gal4 upstream activating sequence (UAS) luciferase reporter (Gal4 DNA binding domain, white; and p65 transactivation domain, gray). F and G: ventricular myocytes were transfected with heterologous fusion proteins comprised of the yeast Gal4 DNA binding domain fused in frame to the transactivation domain of p65NF-B subunit (Gal4p65) or herpes simplex virus VP16 transactivation domain (Gal4VP16) in the absence and presence of HDAC1 or catalytically inactive mutant of HDAC1 (HDAC1H141A). The luciferase reporter activity of the yeast UAS was used to assess Gal4p65 and Gal4VP16 reporter gene transcription by HDAC1. Data were obtained from at least n ϭ 3 to 4 independent myocyte isolations using replicates of n ϭ 3 for each experimental condition tested. *Statistically different (P Ͻ 0.05) from CNTL; ‡statistically different from Gal4p65 (E) or Gal4VP16 (F); †not statistically different from Gal4p65 or Gal4VP16.
and consequently the enzymatic activity of HDAC1 (10, 21, 22) . This view is concordant with our findings that TNF␣ resulted in a marked reduction in HDAC activity despite its nuclear localization. At present it is undetermined whether the inhibitory actions of TNF␣ on HDAC1 activity are direct, indirect, or universally conserved feature of cardiac muscle and is an active area of investigation in our laboratory. Nevertheless, we provide new important evidence for the bidirectional regulation of NF-B and cell survival by HDAC1. The mode by which NF-B transcription regulates cell survival is complex. To date, the NF-B's cellular properties have been ascribed to its role as a transcriptional activator; however, NF-B may under certain instances behave as a transcriptional repressor (1, 2, 28) . Indeed, the survival program initiated by NF-B may involve the dual regulation of survival and death genes in a manner dependent on its acetylation status and recruitment at a given promoter. This notion is supported by the mitochondrial defects and cell death resulting from the increased expression of the death gene Bnip3 in cells defective for NF-B as well as the clinical use of HDAC inhibitors for certain cancers (11, 18) . Therefore, based on our present findings, we speculate that HDAC1 may regulate cell survival by modulating or fine tuning the activity of NF-B-dependent promoters in cell and context-specific manner.
Thus, under the conditions tested, we provide the first evidence for the epigenetic regulation of cardiac cell survival by HDAC1. Selective HDAC inhibition under conditions where TNF␣ levels are elevated may prove beneficial in preserving cardiac muscle and ventricular performance following myocardial infarction or heart failure. 
